Boston Scientific Corporation vs Otis Worldwide Corp — how do they compare? Boston Scientific Corporation trades at $51.05 (market cap $74.19B), while Otis Worldwide Corp trades at $73.25 (market cap $27.80B). The key difference: Boston Scientific Corporation is far larger — about 2.7× Otis Worldwide Corp's market cap, and Otis Worldwide Corp pays a 2.41% dividend while Boston Scientific Corporation pays none. Which is the better fit depends on your goals.
| BSX | OTIS | |
|---|---|---|
Market Cap | $74.19B | $27.80B |
Sector | Health | Industrials |
52-Week High | $108.14 | $93.62 |
52-Week Low | $42.63 | $69.34 |
Enterprise Value | $86.27B | $35.84B |
Dividend Yield | — | 2.41% |
Signals from Pluang's Aura AI — not financial advice
BSX trades at $50.46, up 2.33% today, with strong earnings beats in recent quarters and a bullish technical trend. Revenue grew to $20.07B in 2025, with net income margin expanding to 17.5%. The stock shows robust institutional support and insider buying, while facing near-term headwinds from competitive pressures in key segments like WATCHMAN.
Outlook remains positive with 86% analyst buy ratings and a $67.21 consensus price target, implying 33% upside. Risks include guidance cuts and market share losses, but solid cash flow and valuation metrics support long-term growth potential for patient investors.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, structural heart disease, upper gastrointestinal tract diagnostics, interventional oncology, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
Read more on BSX →Otis is the largest global elevator and escalator supplier by revenue with around one quarter of share excluding Japan. In 1854 Otis' founder and namesake, Elisha Graves Otis, invented a safety mechanism that prevented elevators from falling if the hoisting cable failed.The company's product and service lifecycle begins with installations of elevator units in new buildings, later selling maintenance services on the units, and eventually replacement of the units after the average 15-20 year useful life of an elevator. As the largest global OEM, over decades Otis has built a base of 2 million elevators under service. Its business model is much the same as that of its competitors Kone, Schindler, and Thyssenkrupp.
Read more on OTIS →